These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27616443)

  • 1. Clostridium difficile presence in Spanish and Belgian hospitals.
    Rodriguez C; Fernandez J; Van Broeck J; Taminiau B; Avesani V; Boga JA; Vazquez F; Delmée M; Daube G
    Microb Pathog; 2016 Nov; 100():141-148. PubMed ID: 27616443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular typing and epidemiology of Clostridium difficile in respiratory care wards of central Taiwan.
    Wei HL; Wei SH; Huang CW; Shih CH; Huang YW; Lu MC; Hsu JC; Liou YS; Chiou CS
    J Microbiol Immunol Infect; 2015 Feb; 48(1):65-71. PubMed ID: 23726464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa.
    Kullin B; Wojno J; Abratt V; Reid SJ
    Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):163-175. PubMed ID: 27696234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013.
    Davies KA; Ashwin H; Longshaw CM; Burns DA; Davis GL; Wilcox MH;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27470194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emergence of Clostridium difficile PCR-ribotype 001 in Slovakia.
    Nyc O; Krutova M; Liskova A; Matejkova J; Drabek J; Kuijper EJ
    Eur J Clin Microbiol Infect Dis; 2015 Aug; 34(8):1701-8. PubMed ID: 25981433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.
    Fawley WN; Davies KA; Morris T; Parnell P; Howe R; Wilcox MH;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27487436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile ribotype 126 in southern Taiwan: a cluster of three symptomatic cases.
    Hung YP; Lin HJ; Tsai BY; Liu HC; Liu HC; Lee JC; Wu YH; Wilcox MH; Fawley WN; Hsueh PR; Tsai PJ; Ko WC
    Anaerobe; 2014 Dec; 30():188-92. PubMed ID: 24956433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of Clostridium difficile PCR-ribotype 027 and it's closely related PCR-ribotype 176 in hospitals in Poland in 2008-2010.
    Obuch-Woszczatyński P; Lachowicz D; Schneider A; Mól A; Pawłowska J; Ożdżeńska-Milke E; Pruszczyk P; Wultańska D; Młynarczyk G; Harmanus C; Kuijper EJ; van Belkum A; Pituch H
    Anaerobe; 2014 Aug; 28():13-7. PubMed ID: 24799338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterisation of Czech Clostridium difficile isolates collected in 2013-2015.
    Krutova M; Nyc O; Matejkova J; Allerberger F; Wilcox MH; Kuijper EJ
    Int J Med Microbiol; 2016 Nov; 306(7):479-485. PubMed ID: 27519407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Clostridium difficile in Germany based on a single center long-term surveillance and German-wide genotyping of recent isolates provided to the advisory laboratory for diagnostic reasons.
    von Müller L; Mock M; Halfmann A; Stahlmann J; Simon A; Herrmann M
    Int J Med Microbiol; 2015 Oct; 305(7):807-13. PubMed ID: 26341328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology and resistance profiles of Clostridium difficile in a tertiary care hospital in Spain.
    Weber I; Riera E; Déniz C; Pérez JL; Oliver A; Mena A
    Int J Med Microbiol; 2013 Apr; 303(3):128-33. PubMed ID: 23523477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study.
    Drabek J; Nyc O; Krutova M; Stovicek J; Matejkova J; Keil R
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():55. PubMed ID: 26698842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from a university teaching hospital in Japan.
    Kuwata Y; Tanimoto S; Sawabe E; Shima M; Takahashi Y; Ushizawa H; Fujie T; Koike R; Tojo N; Kubota T; Saito R
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):763-72. PubMed ID: 25471195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of nontoxigenic Clostridium difficile isolated from hospitalized and non-hospitalized individuals in rural Ghana.
    Janssen I; Cooper P; Gunka K; Rupnik M; Wetzel D; Zimmermann O; Groß U
    Int J Med Microbiol; 2016 Dec; 306(8):652-656. PubMed ID: 27693000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.
    Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ;
    Euro Surveill; 2015; 20(38):. PubMed ID: 26536049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical epidemiology of Clostridium difficile infection among hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
    Lopes Cançado GG; Silveira Silva RO; Rupnik M; Nader AP; Starling de Carvalho J; Miana de Mattos Paixão G; Martins Resende BA; Faria Lobato FC; Vilela EG
    Anaerobe; 2018 Dec; 54():65-71. PubMed ID: 30114442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular typing of Clostridioides difficile isolates from clinical and non-clinical samples in Iran.
    Kouhsari E; Douraghi M; Fakhre Yaseri H; Talebi M; Ahmadi A; Sholeh M; Amirmozafari N
    APMIS; 2019 Apr; 127(4):222-227. PubMed ID: 30803047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea.
    Kim H; Jeong SH; Roh KH; Hong SG; Kim JW; Shin MG; Kim MN; Shin HB; Uh Y; Lee H; Lee K
    Korean J Lab Med; 2010 Oct; 30(5):491-7. PubMed ID: 20890081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil.
    Balassiano IT; dos Santos-Filho J; Vital-Brazil JM; Nouér SA; Souza CR; Brazier JS; Ferreira Ede O; Domingues RM
    Antonie Van Leeuwenhoek; 2011 Feb; 99(2):249-55. PubMed ID: 20623188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
    Wilcox MH; Shetty N; Fawley WN; Shemko M; Coen P; Birtles A; Cairns M; Curran MD; Dodgson KJ; Green SM; Hardy KJ; Hawkey PM; Magee JG; Sails AD; Wren MW
    Clin Infect Dis; 2012 Oct; 55(8):1056-63. PubMed ID: 22784871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.